Krysan, Damian J.
University of Iowa
21 papers on CoChatORCID 0000-0001-6330-3365
Most cited papers
- Verified
Drug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology
Antifungal resistance and susceptibilityFungal and yeast genetics research
Cited by 642
- Verified
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Roemer, T., & Krysan, D. J. (2014) · Cold Spring Harbor Perspectives in Medicine
Antifungal resistance and susceptibilityFungal Plant Pathogen Control
Cited by 593
- Verified
Candida albicans Triggers NLRP3-Mediated Pyroptosis in Macrophages
Wellington, M., Koselny, K., Sutterwala, F. S., & Krysan, D. J. (2014) · Eukaryotic Cell
Inflammasome and immune disordersAntifungal resistance and susceptibility
Cited by 227
- Verified
Candida albicans mannans mediate Streptococcus mutans exoenzyme GtfB binding to modulate cross-kingdom biofilm development in vivo
Hwang, G., Liu, Y., Kim, D., Li, Y., Krysan, D. J., & Koo, H. (2017) · PLOS Pathogens
Antifungal resistance and susceptibilityBacterial biofilms and quorum sensing
Cited by 214
- Verified
Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus
Whitesell, L., Robbins, N., Huang, D. S., McLellan, C. A., Shekhar-Guturja, T., LeBlanc, E. V., Nation, C. S., Hui, R., Hutchinson, A., Collins, C., et al. (2019) · Nature Communications
Heat shock proteins researchAntifungal resistance and susceptibility
Cited by 124
- Verified
Antifungal Activity of Tamoxifen: In Vitro and In Vivo Activities and Mechanistic Characterization
Dolan, K., Montgomery, S., Buchheit, B., DiDone, L., Wellington, M., & Krysan, D. J. (2009) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityFungal and yeast genetics research
Cited by 112
- Verified
Estrogen Receptor Antagonists Are Anti-Cryptococcal Agents That Directly Bind EF Hand Proteins and Synergize with Fluconazole In Vivo
Butts, A., Koselny, K., Chabrier-Roselló, Y., Semighini, C. P., Brown, J. C. S., Wang, X., Annadurai, S., DiDone, L., Tabroff, J., Childers, W. E., et al. (2014) · mBio
Fungal Infections and StudiesAntifungal resistance and susceptibility
Cited by 102
- Verified
A Repurposing Approach Identifies Off-Patent Drugs with Fungicidal Cryptococcal Activity, a Common Structural Chemotype, and Pharmacological Properties Relevant to the Treatment of Cryptococcosis
Butts, A., DiDone, L., Koselny, K., Baxter, B. K., Chabrier-Rosello, Y., Wellington, M., & Krysan, D. J. (2013) · Eukaryotic Cell
Fungal Infections and StudiesAntifungal resistance and susceptibility
Cited by 95
- Verified
Unraveling the Biology of a Fungal Meningitis Pathogen Using Chemical Genetics
Brown, J. C. S., Nelson, J., VanderSluis, B., Deshpande, R., Butts, A., Kagan, S., Polacheck, I., Krysan, D. J., Myers, C. L., & Madhani, H. D. (2014) · Cell
Fungal Infections and StudiesFungal and yeast genetics research
Cited by 84
- Verified
The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis
Koselny, K., Green, J., DiDone, L., Halterman, J. P., Fothergill, A. W., Wiederhold, N. P., Patterson, T. F., Cushion, M. T., Rappelye, C., Wellington, M., et al. (2016) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 83
- Verified
The RAM network in pathogenic fungi
Saputo, S., Chabrier-Rosello, Y., Luca, F. C., Kumar, A., & Krysan, D. J. (2012) · Eukaryotic Cell
Fungal and yeast genetics researchAntifungal resistance and susceptibility
Cited by 65
- Verified
The Candida albicans transcription factor Cas5 couples stress responses, drug resistance and cell cycle regulation
Xie, J. L., Qin, L., Miao, Z., Grys, B. T., Diaz, J. D. L. C., Ting, K., Krieger, J. R., Tong, J., Tan, K., Leach, M. D., et al. (2017) · Nature Communications
Fungal and yeast genetics researchAntifungal resistance and susceptibility
Cited by 60
- Verified
Overcoming Fungal Echinocandin Resistance through Inhibition of the Non-essential Stress Kinase Yck2
Caplan, T., Lorente-Macías, Á., Stogios, P. J., Evdokimova, E., Hyde, S., Wellington, M. A., Liston, S., Iyer, K. R., Puumala, E., Shekhar-Guturja, T., et al. (2020) · Cell Chemical Biology
Antifungal resistance and susceptibilityFungal and yeast genetics research
Cited by 57
- Verified
Derivatives of the Antimalarial Drug Mefloquine Are Broad-Spectrum Antifungal Molecules with Activity against Drug-Resistant Clinical Isolates
Montoya, M. C., Beattie, S., Alden, K. M., & Krysan, D. J. (2020) · Antimicrobial Agents and Chemotherapy
Antifungal resistance and susceptibilityFungal Plant Pathogen Control
Cited by 42
- Verified
Fungal-selective resorcylate aminopyrazole Hsp90 inhibitors: optimization of whole-cell anticryptococcal activity and insights into the structural origins of cryptococcal selectivity
Marcyk, P. T., LeBlanc, E. V., Kuntz, D. A., Xue, A., Ortiz, F., Trilles, R., Bengtson, S., Kenney, T. M. G., Huang, D. S., Robbins, N., et al. (2021) · Journal of Medicinal Chemistry
Heat shock proteins researchFungal Infections and Studies
Cited by 40
- Verified
The unmet clinical need of novel antifungal drugs
Krysan, D. J. (2017) · Virulence
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 37
- Verified
Genetic analysis of Hsp90 function in Cryptococcus neoformans highlights key roles in stress tolerance and virulence
Fu, C., Beattie, S. R., Jezewski, A. J., Robbins, N., Whitesell, L., Krysan, D. J., & Cowen, L. E. (2022) · Genetics
Fungal Infections and StudiesHeat shock proteins research
Cited by 31
- Verified
A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.
Ngan, N. T. T., Mai, N. T. H., Tung, N. L. N., Lan, N. P. H., Tai, L. T. H., Phu, N. H., Chau, N. V. V., Binh, T. Q., Hung, L. Q., Beardsley, J., et al. (2019) · Wellcome Open Research
Fungal Infections and StudiesAntifungal resistance and susceptibility
Cited by 28
- Verified
Claims of equivalence in randomized controlled trials of the treatment of bacterial meningitis in children
KRYSAN, D. J., & KEMPER, A. R. (2002) · The Pediatric Infectious Disease Journal
Statistical Methods in Clinical TrialsBacterial Infections and Vaccines
Cited by 27
- Verified
High-Throughput Screen in Cryptococcus neoformans Identifies a Novel Molecular Scaffold That Inhibits Cell Wall Integrity Pathway Signaling
Hartland, K., Pu, J., Palmer, M., Dandapani, S., Moquist, P. N., Munoz, B., DiDone, L., Schreiber, S. L., & Krysan, D. J. (2016) · ACS Infectious Diseases
Fungal Infections and StudiesAntifungal resistance and susceptibility
Cited by 24
- Verified
Benzothiourea Derivatives Target the Secretory Pathway of the Human Fungal Pathogen Cryptococcus neoformans
Beattie, S. R., Schnicker, N. J., Murante, T., Kettimuthu, K., Williams, N. S., Gakhar, L., & Krysan, D. J. (2020) · ACS Infectious Diseases
Fungal Infections and StudiesAntifungal resistance and susceptibility
Cited by 10
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free